---
title: Use of class IC antiarrhythmic drugs in patients with structural heart disease
  and implantable cardioverter defibrillator
date: '2024-02-19'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38372753/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240219170653&v=2.18.0
source: heidelberg[Affiliation]
description: 'CONCLUSION: In a multicenter cohort of ICD-carriers with SHD, class-IC-AADs
  were associated with a low rate of pro-arrhythmic effects or cardiovascular mortality.
  The majority of patients remained free from sustained VA during a follow-up of >
  2 years. Further efforts should be made to evaluate the safety of class-IC-AADs
  in SHD patients receiving contemporary cardiovascular ...'
disable_comments: true
---
CONCLUSION: In a multicenter cohort of ICD-carriers with SHD, class-IC-AADs were associated with a low rate of pro-arrhythmic effects or cardiovascular mortality. The majority of patients remained free from sustained VA during a follow-up of > 2 years. Further efforts should be made to evaluate the safety of class-IC-AADs in SHD patients receiving contemporary cardiovascular ...